1488 studies found for:    "Ovarian Neoplasms"
Show Display Options
Rank Status Study
21 Active, not recruiting Activity, Tolerability, Safety of Temsirolimus in Women With Ovarian Cancer Who Progressed During Previous Platinum Chemotherapy or Within 6 Months After Therapy or Advanced Endometrial Carcinoma
Conditions: Genital Diseases, Female;   Ovarian Diseases;   Ovarian Neoplasms;   Endometrial Neoplasms
Intervention: Drug: Temsirolimus
22 Unknown  Neoadjuvant Chemotherapy With Carboplatin and Docetaxel in Patients With Advanced Ovarian Cancer-Prospective, Randomized Phase II Clinical Trial
Condition: Ovarian Neoplasms
Intervention: Procedure: neoadjuvant chemotherapy (Carboplatin/Docetaxel)
23 Completed Evaluation of Vasopressin in the Vessels of Ovarian Neoplasms
Condition: Ovarian Neoplasms
Intervention: Procedure: removal of ovarian vessels
24 Completed
Has Results
Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites
Conditions: Ovarian Neoplasms;   Ascites
Interventions: Drug: aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®);   Drug: Placebo
25 Enrolling by invitation International Ovarian Tumour Analysis (IOTA) Phase 5
Conditions: Adnexal Masses;   Ovarian Cysts;   Ovarian Tumors
Intervention:
26 Recruiting Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer
Conditions: Ovarian Diseases;   Ovarian Neoplasms
Interventions: Other: Laboratory Tumor Marker Analysis;   Other: Transvaginal Ultrasound;   Other: Health Status Questionnaire
27 Completed DOXIL for Consolidation Therapy in Ovarian Cancer.
Condition: Ovarian Neoplasm
Intervention: Drug: liposomal doxorubicin
28 Completed A Study of Trabectedin in Patients With Advanced Ovarian Cancer
Conditions: Ovarian Neoplasms;   Endocrine Gland Neoplasms;   Neoplasms by Site;   Neoplasms;   Ovarian Diseases;   Adnexal Diseases;   Genital Diseases, Female
Interventions: Drug: Trabectedin;   Drug: Dexamethasone
29 Unknown  [18F]Fluciclatide-PET, Pazopanib and Paclitaxel in Ovarian Cancer
Condition: Ovarian Neoplasm
Intervention: Drug: Pazopanib and paclitaxel
30 Completed Study of OSI-211 vs. Topotecan in Patients With Relapsed Epithelial Ovarian Cancer
Condition: Ovarian Neoplasms
Intervention: Drug: OSI-211 (Liposomal Lurtotecan)
31 Completed 89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients
Conditions: Ovarian Neoplasms;   Ovarian Diseases;   Adnexal Diseases;   Pancreatic Neoplasms;   Digestive System Neoplasms;   Digestive System Diseases;   Pancreatic Diseases
Intervention: Drug: 89Zr-MMOT0530A
32 Terminated Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Conditions: Neoplasms;   Ovarian Neoplasms;   Fallopian Tube Neoplasms;   Primary Peritoneal Neoplasm
Interventions: Biological: KHK2866;   Drug: Gemcitabine and Carboplatin;   Drug: paclitaxel;   Drug: pegylated liposomal doxorubicin
33 Completed A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian Cancer
Condition: Ovarian Neoplasm
Interventions: Drug: Cyclophosphamide;   Drug: Paclitaxel;   Drug: Cisplatin;   Drug: G-CSF
34 Completed A Pilot Study of a Protein Profile Test in Ovarian Cancer Patients in Remission to See if Protein Changes Can Predict Relapse (be Predictive of Cancer Relapse)
Condition: Ovarian Neoplasm
Intervention:
35 Recruiting Safety, Feasibility and Effect of TTFields Concomitant With Weekly Paclitaxel in Recurrent Ovarian Carcinoma
Condition: Ovarian Carcinoma
Interventions: Device: NovoTTF-100L(O);   Drug: Paclitaxel
36 Active, not recruiting Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Ovarian Cancer
Condition: Ovarian Neoplasm
Intervention: Drug: KU-0059436 (AZD2281)(PARP inhibitor)
37 Completed
Has Results
Phase II Study of Clinical Activity of Pegaspargase in Women With Relapsed or Refractory Epithelial Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
Conditions: Ovarian Neoplasms;   Fallopian Tube Neoplasms;   Primary Peritoneal Neoplasms
Intervention: Drug: Pegylated L-Asparaginase
38 Completed Study of the Combination Carboplatin Plus Celecoxib in Heavily Pre-treated Recurrent Ovarian Cancer Patients
Condition: Ovarian Neoplasms
Intervention: Drug: Carboplatin plus Celecoxib
39 Recruiting Feasibility Study of HIPEC for Patients With Stage III or Only Pleural Stage IV Ovarian Carcinoma in First Line Therapy
Conditions: Ovarian Carcinoma;   Fallopian Tube Carcinoma;   Primary Peritoneal Carcinoma
Intervention: Procedure: HIPEC
40 Recruiting Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer
Conditions: Stage III Ovarian Cancer;   Stage IV Ovarian Cancer;   Uterine Cancer
Interventions: Drug: Olaparib;   Drug: Carboplatin;   Drug: Paclitaxel

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years